Its amusing that my word processor is now just as processor intensive as many of the computer games I play. That program is really amazing! So much so, that I decided to buy it. Re: TeX => TeXmacs => back to TeX via BaKoMa So basically, faster computers made TeXmacs possible but even faster computers may make it unnecessary!ĭropZap - a new kind of block elimination game But with even faster computers, BaKoMa TeX Word gives us truely WYSIWYG LaTeX by simply running TeX in the background - all that TeXmacs incremental cleverness is not so important when your computer is really fast and your document is not that long (e.g., for conference papers). Some clever programming made this possible. What you see while editing is exactly what you get in the output. With faster computers, TeXmacs came along to give you a truely WYSIWYG TeX-like real-time typesetter. Topic: TeX => TeXmacs => back to TeX via BaKoMa TeX (Read 4450 times) TeX => TeXmacs => back to TeX via BaKoMa TeX General problem-solving / chatting / whatever (Moderators: ThudnBlunder, william wu, SMQ, Eigenray, towr, Grimbal, Icarus) RIDDLES SITE WRITE MATH! Home Help Search Members Login Register « wu :: forums - TeX => TeXmacs => back to TeX via BaKoMa TeX »

239000011616 biotin Substances 0.Wu :: forums - TeX => TeXmacs => back to TeX via BaKoMa TeX.

108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 329.

230000001603 reducing Effects 0.000 claims abstract description 31.

108020004707 nucleic acids Proteins 0.000 claims abstract description 35.

150000007523 nucleic acids Chemical class 0.000 claims abstract description 38.

230000002463 transducing Effects 0.000 claims abstract description 53.

239000008280 blood Substances 0.000 claims abstract description 58.

210000004369 Blood Anatomy 0.000 claims abstract description 58.

230000001939 inductive effect Effects 0.000 claims abstract description 78.

239000003795 chemical substances by application Substances 0.000 claims abstract description 79.

230000014509 gene expression Effects 0.000 claims abstract description 94.

229920001184 polypeptide Polymers 0.000 claims abstract description 100.

239000002245 particle Substances 0.000 claims abstract description 228.

230000027455 binding Effects 0.000 claims abstract description 230.

$cases in texmacs$

239000000203 mixture Substances 0.000 claims abstract description 245.210000001744 T-Lymphocytes Anatomy 0.000 claims abstract description 286.108091007172 antigens Proteins 0.000 claims abstract description 318.102000038129 antigens Human genes 0.000 claims abstract description 318.239000000427 antigen Substances 0.000 claims abstract description 318.238000000338 in vitro Methods 0.000 title claims abstract description 23.230000003211 malignant Effects 0.000 title claims abstract description 362.KG Publication of WO2021047804A1 publication Critical patent/WO2021047804A1/en Links Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.) Filing date Publication date Priority to EP19196735.5 priority Critical Priority to EP19196735 priority Application filed by Miltenyi Biotec B.V. KG Priority date (The priority date is an assumption and is not a legal conclusion. Inventor Nicole CORDES Thomas SCHASER Andrew Kaiser Original Assignee Miltenyi Biotec B.V. Google Patents WO2021047804A1 - In vitro method for transduction of t cells in the presence of malignant cells WO2021047804A1 - In vitro method for transduction of t cells in the presence of malignant cells

Cases in texmacs